Elanco Animal Health (NYSE:ELAN) reported Q2 EPS of $0.36, $0.11 better than the analyst estimate of $0.25. Revenue for the quarter came in at $1.18 billion versus the consensus estimate of $1.18 billion.
GUIDANCE:
Elanco Animal Health sees Q3 2022 EPS of $0.12-$0.18, versus the consensus of $0.26. Elanco Animal Health sees Q3 2022 revenue of $1.01-1.06 billion, versus the consensus of $1.14 billion.